J Joyner - CVS Health Insider

CVS -- USA Stock  

USD 71.08  1.10  1.52%

Executive Vice President

Mr. J. David Joyner is Executive Vice President of the Company. Mr. Joyner Executive Vice President of Sales and Account Services, CVS Caremark since March 2004.
Age: 51  President Since 2011      
401-765-1500  http://www.cvshealth.com
Joyner earned a bachelor degree in business administration, majoring in finance, from Texas Tech University in Lubbock, Texas and holds a certified employee benefit specialist designation.

J Joyner Latest Insider Activity

Management Efficiency

The company has Return on Asset of 5.55 % which means that on every $100 spent on asset it made $5.55 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.39 % implying that it generated $18.39 on every 100 dollars invested.
The company has 65.09 B in debt with debt to equity (D/E) ratio of 168.3 . This implies that the company may be unable to create cash to meet all of its financial commitments. CVS Health Corporation has Current Ratio of 2.32 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Ravi ChariHCA Healthcare
2015
Bob KneeleyEnvision Healthcare Corporation
2017
Christopher IsaakCentene Corporation
2016
Robert CowardEnvision Healthcare Corporation
2016
Deborah ReinerHCA Healthcare
2017
Kevin CounihanCentene Corporation
2017
Jana DavisHCA Healthcare
2012
Christopher KosterCentene Corporation
2017
Michael StanleyMEDNAX
2015
Martin SmithCommunity Health Systems
2015
Tim HingtgenCommunity Health Systems
2016
Paul PaslickHCA Healthcare
2012
Thomas AaronCommunity Health Systems
2017
Charles LynchMEDNAX
2014
Michael PortacciCommunity Health Systems
N/A
Thomas MillerCommunity Health Systems
2015
Paul SmithCommunity Health Systems
2015
Heather RohanHCA Healthcare
2016
Alan YuspehHCA Healthcare
2010
Michael CuffeHCA Healthcare
2011
William KlitgaardLaboratory Corporation of Ameri
2015

Entity Summary

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island. CVS Health operates under Health Care Plans classification in USA and traded on New York Stock Exchange. It employs 160000 people.CVS Health Corporation (CVS) is traded on New York Stock Exchange in USA. It is located in RHODE ISLAND, U.S.A and employs 160,000 people. CVS Health is listed under Retail category by Fama And French industry classification.

CVS Health Leadership Team

J Joyner, President
David Dorman, Chairman
Richard Bracken, Director
Mary Schapiro, Director
Richard Swift, Director, MBA
NancyAnn DeParle, Director
David Brown, Director
JeanPierre Millon, Director, MBA
Alecia DeCoudreaux, Director
William Weldon, Director
Kevin Hourican, President
Stephen Gold, President
Troyen Brennan, President, Ph.D
Lisa Bisaccia, President
David Denton, CFO
Helena Foulkes, President
Thomas Moriarty, EVP
Tony White, Director
Anne Finucane, Director
Derica Rice, President
Per Lofberg, President
Eva Boratto, SVP
David Joyner, President
Jonathan Roberts, President
Larry Merlo, CEO
Andrew Sussman, President, Ph.D
Robert Kraft, President

Stock Performance Indicators

Current Sentiment - CVS

CVS Health Investor Sentiment
Predominant part of Macroaxis users are currently bullish on CVS Health Corporation. What is your opinion about investing in CVS Health Corporation? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for CVS Health and Laboratory of America. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.